Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Quiver Bioscience develops medicines for brain disorders using human disease models and advanced AI technologies.
Cellular Logistics specializes in a cellular biomaterial as a stand-alone therapeutic for cardiac and tissue vascularization applications.
Matter Bio operates as company focus on preserving genome integrity.
A medical device company with a non-invasive treatment for infected metallic implants in the body.
Psilera is a biotechnology company that develops treatments for neurological and psychiatric disorders.
Domus Diagnostics provides a care diagnostics platform that offers respiratory disease home testing services.
Insilica is a bioinformatics company.
InformAI delivers AI-enabled clinical solution focused on oncology and diagnostic imaging to improve patient outcomes.
Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.
Hepatx is developing regenerative medicine solutions.
Levisonics is a manufacturer of blood coagulation devices created to perform non-contact analysis of blood coagulation.
Micro-Leads Medical is a medical technology company dedicated to developing innovative therapies that address the neuromodulation.
Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.
PhagePro is an early-stage biotechnology therapeutics company.
Pulvinar Neuro is to enable and support outstanding basic and translational neuroscience research.
Amygdala Neuroscience is a free online portal to create group projects and media item related to neuroscience.
Eliaz Therapeutics is developing a novel treatment using targeted therapeutic apheresis to remove Galetin-3 from the body
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration.
Sparian Biosciences is a biopharmaceutical company.
Magnasense will create technology for biomarker assays that are easily accessible.
TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.
Enable Biosciences is a biotech company.
Aqualung Therapeutics is developing a novel, anti-inflammatory monoclonal antibody strategy to treat serious unchecked inflammation.
AcuraStem harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS.
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Biotechnology, Health Care, Life Science, Medical, Pharmaceutical. The firm invests across 20 different industry categories.
Among tracked funding rounds, Allyx Therapeutics received $26.5M in a Series B round. National Institutes of Health's total known invested capital is $2.2B.
National Institutes of Health's average investment size is $5.0M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include Quiver Bioscience, Cellular Logistics, Matter Bio, Solenic Medical, Psilera. These companies were founded in 2020 or later.